Mendel Tuchman MD
Clinical Biochemical Genetics, Clinical Genetics
Professor, Pediatrics, G Washington University School of Medicine & Hlth
Join to View Full Profile
111 Michigan Ave NwWashington, DC 20010
Phone+1 202-884-2187
Are you Dr. Tuchman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mendel Tuchman, MD is a medical geneticist in Washington, District of Columbia. He is currently licensed to practice medicine in Maryland and Virginia. He is a Professor at G Washington University School of Medicine & Hlth.
Education & Training
University of MinnesotaResidency, Pediatrics, 1980 - 1985
Tel Aviv University SacklerClass of 1979- University of MinnesotaFellowship, Medical Genetics and Genomics
Certifications & Licensure
MD State Medical License 2001 - 2025
VA State Medical License 2001 - 2022
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 4 citationsNon-coding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene.Johannes Häberle, Marvin B Moore, Nantaporn Haskins, Véronique Rüfenacht, Dariusz Rokicki
Human Mutation. 2021-09-12 - 10 citationsGene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthaseParthasarathy Sonaimuthu, Emilee Senkevitch, Nantaporn Haskins, Prech Uapinyoying, M McNutt
Scientific Reports. 2021-02-11 - 13 citationsMitochondrial Enzymes of the Urea Cycle Cluster at the Inner Mitochondrial MembraneNantaporn Haskins, Shivaprasad Bhuvanendran, Claudio Anselmi, Anna Gams, Tomas Kanholm
Frontiers in Physiology. 2021-01-21
Press Mentions
RECORDATI RARE DISEASES: CARBAGLU® (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic AcidemiaJanuary 26th, 2021
$5 Million in Federal Funding to Help Patients with Urea Cycle DisordersOctober 24th, 2019
